FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: Elon Musk's SpaceX Speeds Up IPO, Eyes June 12 Nasdaq Debut

By

Elon Musk's rocket and satellite company SpaceX has accelerated its highly anticipated initial public offering, now targeting pricing as early as June 11, with Nasdaq chosen as its listing venue, Reuters reported Friday, citing people familiar with the matter.

The company may make its prospectus public as early as next Wednesday, with a roadshow launch set for June 4 and a market debut expected on June 12, the media outlet added.

Advancement of the IPO timeline, initially scheduled for late June, follows a faster-than-expected review of the company's filing by the US Securities and Exchange Commission.

SpaceX did not immediately respond to a request for comment from.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: $424.48, Change: $-18.82, Percent Change: -4.25%

Related Articles

Australia

Krystal Biotech's Medicine to Treat Wounds in Dystrophic Epidermolysis Bullosa Gets Approval in UK

Krystal Biotech's (KRYS) beremagene geperpavec to treat wounds in patients with dystrophic epidermolysis bullosa has received approval from the UK's Medicines and Healthcare products Regulatory Agency for use from birth onward, the agency said in a Friday statement.The medication, which is available in the form of gel, demonstrated 67% complete healing rate in a study of 31 patients at six months, according to the statement.Dystrophic epidermolysis bullosa is a rare genetic condition characterized by fragile skin and recurrent wounds.Price: $308.93, Change: $-7.37, Percent Change: -2.33%

$KRYS
Australia

Manulife Financial's Canada Business May Rebound Earlier, Stronger Than Expected, RBC Says

Manulife Financial's (MFC) Canada business may rebound earlier and more strongly than expected but sustained outperformance would require stronger contributions from Asia and Global Wealth and Asset Management, RBC Capital Markets said Friday.The company's Q1 core EPS was CA$1.06 ($0.77), below RBC's estimate of CA$1.11 and consensus of CA$1.10. The miss was driven by weaker-than-expected results in Canada, Corporate & Other, and Global Wealth and Asset Management, according to the note.RBC lowered its core EPS estimates to CA$4.44 from CA$4.57 in 2026 and to CA$4.90 from CA$4.97 in 2027.Canada core earnings of CA$352 million were below RBC's estimate of CA$409 million. The firm expects Canada insurance experience to normalize by year-end but models Canada core earnings to decline about 6% in 2026.Corporate & Other posted a core loss of CA$115 million, larger than RBC's expected loss of CA$65 million, while GWAM core earnings of CA$448 million also came in below forecast.RBC kept an outperform rating on Manulife Financial with a price target of CA$55.Price: $37.52, Change: $-0.02, Percent Change: -0.05%

$MFC
Australia

Gambling.com Shares Fall After Guidance Cut

Gambling.com (GAMB) shares were down over 41% in Friday trading after the company lowered its 2026 guidance.Late Thursday, the firm said it now expects 2026 revenue of $165 million to $170 million and adjusted EBITDA of $45 million to $50 million.Previously, it expected revenue of $170 million to $180 million and adjusted EBITDA of $50 million to $58 million for the year.Analysts expected revenue of $172 million in a FactSet poll.The company also reported a Q1 adjusted EPS of $0.09 on revenue $40.4 million. Analysts expected $40.2 million revenue.The firm also said it will undertake an AI-driven restructuring that includes cutting its workforce by 25%, a move expected to generate $13 million in annualized savings.After the results, Benchmark rated the stock a speculative buy, against buy previously, and cut its price target to $4 from $6.Price: $2.41, Change: $-1.74, Percent Change: -41.91%

$GAMB